← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Net income increased 107.1% to $4.8M, while Operating cash flow increased 27.2% to ($43.9M).
The read at a glance✓ Audited against SEC data
- Scale — FY2025 revenue N/AOK
- Profitability — Net income $4.8MOK
- Cash generation — Free cash flow N/ANote
- Accounting — Formula-grey distress score · manipulation and earnings-quality screens not computedNote
- Insiders — 0 buys; 4 sells in 365 daysNote
- Capital — Comparable payout data unavailableNote
Business
CYPHERPUNK TECHNOLOGIES INC.: We obtained the industry, market and competitive position data in this Annual Report from our own internal estimates and research as well as from industry and general publications and research surveys and studies conducted by third parties.
Leadership changes
From CYPHERPUNK TECHNOLOGIES INC.'s own filings, the day they're filed.
- Cyndi Sirard · Chief Medical Officer · departureeff. 2025-06-30
- Joseph Loscalzo · Directors · departure
Latest filings
- 8-K · Company announcement2026-09-02
- 8-K · Company announcement2026-08-18
- 8-K · Company announcement2026-08-12
- 10-Q · Quarterly report2026-08-12
- 8-K · Company announcement2026-07-21
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about CYPHERPUNK TECHNOLOGIES INC., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.